NANOVIRICIDES, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nanoviricides, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Nanoviricides, Inc. Return On Equity for the quarter ending June 30, 2024 was -69.8 %, a 51.4% decline year-over-year.
  • Nanoviricides, Inc. annual Return On Equity for 2024 was -69.8 %, a 51.4% decline from 2023.
  • Nanoviricides, Inc. annual Return On Equity for 2023 was -46.1 %, a 45.9% decline from 2022.
  • Nanoviricides, Inc. annual Return On Equity for 2022 was -31.6 %, a 7.05% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -69.8 -23.7 -51.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -74.7 -41.8 -127% Jan 1, 2024 Mar 31, 2024
Q4 2023 -64 -33.1 -107% Oct 1, 2023 Dec 31, 2023
Q3 2023 -54.5 -25.1 -85% Jul 1, 2023 Sep 30, 2023
Q2 2023 -46.1 -14.5 -45.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.9 -2.17 -7.07% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.9 -0.96 -3.21% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29.5 +1.49 +4.81% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.6 -2.08 -7.05% Apr 1, 2022 Jun 30, 2022
Q1 2022 -30.7 +0.27 +0.87% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.9 +32.4 +52% Oct 1, 2021 Dec 31, 2021
Q3 2021 -31 +46 +59.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -29.5 +72.1 +70.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -31 +101 +76.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -62.3 +15.8 +20.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -77 -6.59 -9.36% Jul 1, 2020 Sep 30, 2020
Q2 2020 -102 -38.2 -60.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -132 -79.8 -153% Jan 1, 2020 Mar 31, 2020
Q4 2019 -78.1 -31.1 -66% Oct 1, 2019 Dec 31, 2019
Q3 2019 -70.4 -21.5 -43.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -63.4 -15.3 -31.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -52.3 -0.99 -1.93% Jan 1, 2019 Mar 31, 2019
Q4 2018 -47 +7.4 +13.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -48.9 -2.88 -6.26% Jul 1, 2018 Sep 30, 2018
Q2 2018 -48.1 +2.13 +4.24% Apr 1, 2018 Jun 30, 2018
Q1 2018 -51.3 -6.94 -15.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -54.4 -2.34 -4.49% Oct 1, 2017 Dec 31, 2017
Q3 2017 -46 +6.18 +11.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -50.2 -9.78 -24.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -44.3 -9.52 -27.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -52.1 -35 -204% Oct 1, 2016 Dec 31, 2016
Q3 2016 -52.2 -38.2 -274% Jul 1, 2016 Sep 30, 2016
Q2 2016 -40.4 -33.5 -481% Apr 1, 2016 Jun 30, 2016
Q1 2016 -34.8 -6.71 -23.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -17.1 +6.42 +27.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -14 +13.4 +48.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -6.96 +74.6 +91.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -28.1 +40.3 +58.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -23.5 +141 +85.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -27.3 +107 +79.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -81.5 -2.9 -3.69% Apr 1, 2014 Jun 30, 2014
Q1 2014 -68.4 -2.97 -4.54% Jan 1, 2014 Mar 31, 2014
Q4 2013 -164 -99 -151% Oct 1, 2013 Dec 31, 2013
Q3 2013 -134 -63.7 -90.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -78.6 -12.7 -19.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -65.4 +3.17 +4.62% Jan 1, 2013 Mar 31, 2013
Q4 2012 -65.5 Oct 1, 2012 Dec 31, 2012
Q3 2012 -70.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -66 Apr 1, 2012 Jun 30, 2012
Q1 2012 -68.6 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.